MedTrace Logo

Pharmacist-led Group Medical Visits to Help With Diabetes Management

NCT00554671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-07-11

Study results available
· View outcomes & findings →

Summary

This is a multi-site open label randomized controlled study of patients with type 2 diabetes undergoing pharmacist-led group medical visits that include education by a multi-disciplinary personnel, behavioral modification and pharmacotherapy case management vs. usual care

Conditions

Interventions

OTHER

Algorithm driven medication titration

Clinical pharmacists will change medications to achieve goals in hypertension, dyslipidemia and diabetes

BEHAVIORAL

Monitoring

Clinical pharmacists will monitor the progress of patients in lifestyle modification and cardiac risk factor control goals

BEHAVIORAL

Group support

Peer support are provided in the group setting

BEHAVIORAL

Self efficacy

Patients are taught with self-monitoring skills for diabetes and blood pressure, as well as healthy cooking and practiced under supervision

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Wen-Chih H Wu, MD · Providence VA Medical Center, Providence, RI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2011-12-31
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00554671 on ClinicalTrials.gov